Neurofibroma diagnostic criteria

Jump to navigation Jump to search

Neurofibroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neurofibroma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neurofibroma diagnostic criteria On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neurofibroma diagnostic criteria

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neurofibroma diagnostic criteria

CDC on Neurofibroma diagnostic criteria

Neurofibroma diagnostic criteria in the news

Blogs on Neurofibroma diagnostic criteria

Directions to Hospitals Treating Neurofibroma

Risk calculators and risk factors for Neurofibroma diagnostic criteria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]

Overview

Diagnostic criteria

Following is the general diagnostic criteria for neurofibroma:

  • Randomly oriented thin spindled cells with wavy, hyperchromatic nuclei
    • Cellularity and organization are generally insufficient to produce palisading
    • Thin processes with indistinct cytoplasm
    • Most nuclei are small and bland
  • Generally hypocellular
    • Thin and thick collagen strands (“shredded carrot collagen”)
    • Variable myxoid material surrounding cells and collagen
    • Occasional mast cells and lymphocytes, rare foam cells
  • Diffusely S100 immunoreactive
  • Entrapped axons of overrun nerve frequently scattered within lesion
    • Nerve frequently not grossly identifiable
  • May show localized hyperchromatic atypical cells (“ancient change”)
    • Localized cells with large, pleomorphic nuclei, cytoplasmic intranuclear inclusions, smudgy chromatin, and inconspicuous nucleoli
    • Often large, long standing lesions
    • Low mitotic index

References


Template:WikiDoc Sources